Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
View cart
Account
Ordering help
MSDS
Home Products Protocols Technical Support About Us Contact Us
Cbl (C14) Blocking Peptide
 
Print Page  
 
Adobe PDF
Contents: Cbl (C14) Blocking Peptide
Catalog Number: 66-P760
Formulation: Each vial contains 100 μg of peptide in 0.5 ml PBS with 0.1% NaN3 and 100 μg BSA.
Storage Conditions: Store at 4°C.
DO NOT FREEZE.

Prices for This Product*
Cat. No. Size Price Qty Action
66-P760-81 50 ug $25
*International customers: Please contact your distributor for region specific pricing.

   

Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
66-P760 Blocking Peptides for anti-mouse/human/rat Cbl polyclonal N/A N/A WB 

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.


Description


This is a peptide mapping to the carboxy terminal domain of human Cbl p120. The proto-oncogene c-Cbl was initially identified as the cellular homologue of v-Cbl oncogene that induces pre-B cell lymphomas and myeloid leukemias in mice (1&2). In more recent studies Cbl has been shown to be a negative regulator of tyrosine kinase signaling (2-4). The ubiquitin ligase activity of Cbl leads to the degradation of tyrosine kinases, thus attenuating the signal of receptors (3&4). Targets of Cbl include activated protein tyrosine kinases belonging to the Src and Syk/Zap-70 families (3). An additional mechanism to attenuate receptor signaling is thought to be achieved by Cbl?s interaction with downstream targets of tyrosine kinases, such as PI-3K and Vav (1&3).


Applications Reported


For research use only, not for diagnostic or therapeutic use. This blocking peptide has been reported for use in competition studies.


References



1. Liu YC, Altman A. 1998. Cbl: complex formation and functional implications. Cell Signal 10(6):377-385.
2. Miyake S, Lupher ML, Andoniou CE, Lill NL, Ota S, Douillard P, Rao N, Band H. 1997. The Cbl protooncogen product: from an enigmatic oncogene to center stage of signal transduction. Crit Rev Oncog 8(2-3):189-218.
3. Rao N, Dodge I, Band H. 2002. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J Leukoc Biol 71(5):753-763.
4. Sanjay A, Horne WC, Baron R. 2001. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinase. Sci STKE 2001(110):PE40.


Related Products


Cat. 14-6760    Purified anti-mouse/human/rat Cbl polyclonal (clone Polyclonal)


Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2008 eBioscience, Inc.
Product For Research Use Only: Not for further distribution without written consent.